Stellate ganglion block inhibits formalin-induced nociceptive responses: Mechanism of action

European Journal of Anaesthesiology

Volumn 22, Issue 12, 2005, Pages 913-918

  Wang, Q X ^a,b   Wang, X Y ^a   Fu, N A ^a   Liu, J Y ^a   Yao, S L ^b  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Anaesthetic technique, stellate ganglion block; Catecholamines, norepinephrine; Local anaesthetics, bupivacaine; Rabbit; Substance P

Indexed keywords

FORMALDEHYDE; SUBSTANCE P; URETHAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CERVICAL SPINAL CORD; CERVICAL SPINE; CONTROLLED STUDY; DRUG EFFICACY; IMMUNOREACTIVITY; MALE; NOCICEPTION; NONHUMAN; PROTEIN EXPRESSION; RABBIT; STELLATE GANGLION;

ANALGESIA; ANESTHETICS, LOCAL; ANIMALS; AUTONOMIC NERVE BLOCK; BEHAVIOR, ANIMAL; BUPIVACAINE; FORMALDEHYDE; MALE; NOREPINEPHRINE; PAIN; PAIN MEASUREMENT; PROTO-ONCOGENE PROTEINS C-FOS; RABBITS; SPINAL CORD; STELLATE GANGLION; SUBSTANCE P;

EID: 28444497798     PISSN: 02650215     EISSN: 02650215     Source Type: Journal    
DOI: 10.1017/S0265021505001559     Document Type: Article

References (26)

1. Koyama S, Sato N, Nagashima K et al. Effects of right stellate ganglion block on the autonomic nervous function of the heart: a study using the Head-up Tilt Test. Circ J 2002; 66: 645-648.
2. Schürmann M, Gradl G, Wizgal I et al. Clinical and physiologic evaluation of stellate ganglion blockade for complex regional pain syndrome Type I. Clin J Pain 2001; 17: 94-100.
3. Parris WCV, Lin S, Frist W. Use of stellate ganglion block for chronic chest pain associated with primary pulmonary hypertention. Anesth Analg 1988; 67: 993-995.
4. Hogan QH, Abram SE. Neural blockade for diagnosis and prognosis: a review. Anesthesiology 1997; 86: 216-241.
5. Powell KJ, Quirion R, Jhamandas K. Inhibition of neurokinin-1-substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CGRP expression in cultured dorsal root ganglion neurons. Eur J Neurosci 2003; 18: 1572-1583.
6. Gilron I, Quirion R, Coderre TJ. Pre- vs. postformalin effects of ketamine or large-dose alfentanil in the rat: discordance between pain behavior and spinal fos-like immunoreactivity. Anesth Analg 1999; 89: 128-135.
7. Kinnman E, Levine JD. Involvement of the sympathetic postganglionic neuron in capsaicin-induced secondary hyperalgesia in the rat. Neuroscience 1995; 65: 283-291.
8. Kinnman E, Nygards EB, Hansson P. Peripheral α-adrenoreceptors are involved in the development of caspsaicin induced ongoing and stimulus evoked pain in human. Pain 1997; 69: 79-85.
9. Drummond PD. Noradrenaline increases hyperalgesia to heat in skin sensitised by capsaicin. Pain 1995; 60: 311-315.
10. Drummond PD. Enhancement of thermal hyperalgesia by alpha-adrenoceptors in capsaicin-treated skin. J Auto Nerv Syst 1998; 69: 96-102.
11. Dorazil-Dudzik M, Mika J, Schafer MKH et al. The effects of local pentoxifylline and propentofylline treatment on formalin-induced pain and tumor necrosis factor-[alpha] messenger RNA levels in the inflamed tissue of the rat paw. Anesth Analg 2004; 98: 1566-1573.
12. McDonald JS, Pensak ML, Phero JC. Part II: thoughts on the management of chronic facial, head, and neck pain. Am J Oncol 1990; 11: 378-382.
13. Suzuki H, Yoshioka K, Maehara T et al. Differential effects of wortmannin on the release of substance P and amino acids from the isolated spinal cord of the neonatal rat. Br J Pharmacol 1998; 125: 1661-1668.
14. Kuraishi Y, Hirota N, Sato Y et al. Evidence that substance P and somatostatin transmit separate information related to pain in the spinal dorsal horn. Brain Res 1985; 325: 294-298.
15. Ruan HZ, Li XC, Cai WQ. Effect of 5-HT on pain modulation of substance P in spinal cord of rats. Zhongguo Yao Li Xue Bao 1995; 16: 512-516.
16. Duggan AW, Hendry IA, Morton CR et al. Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat. Brain Res 1988; 451: 261-273.
17. Regoli D, Drapeau G, Dion S, D'Orleans JP. Receptors for substance P and related neurokinins. Pharmacology 1989; 38: 1-15.
18. Polgar E, Szucs P, Urban L, Nagy I. Alterations of substance P immunocreativity in lumbar and thoratic segments of rat spinal cord in ultraviolet irradiation induced hyperalgesia of the hind paw. Brain Res 1998; 786: 248-251.
19. Raja SN. Role of the sympathetic nervous system in acute pain and inflammation. Ann Med 1995; 27: 241-246.
20. Janig W, Habler HJ. Sympathetic nervous system: contribution to chronic pain. Brain Res 2000; 129: 451-468.
21. Ren Y, Zou X, Fang L, Lin Q. Sympathetic modulation of activity in Aδ and C primary nociceptive afferents following intradermal injection of capsaicin in rats. J Neurophysiol 2004; 15 (Epub ahead of print).
22. Yokoyama M, Nakatsuka H, Itano Y, Hirakawa M. Stellate ganglion block modifies the distribution of lymphocyte subsets and natural-killer cell activity. Anesthesiology 2000; 92: 109-115.
23. Torebjork E, Wahren L, Wallin G, Hallin R, Koltzenburg M. Noradrenaline-evoked pain in neuralgia. Pain 1995; 63: 11-20.
24. Li XQ, Clark JD. Hyperalgesia during opioid abstinence: mediation by glutamate and substance P. Anesth Analg 2002; 95: 979-984.
25. Zhang GH, Min SS, Lee KS et al. Intraarticular pretreatment with ketamine and memantine could prevent arthritic pain: relevance to the decrease of spinal c-Fos expression in rats. Anesth Analg 2004; 99: 152-158.
26. Kingery WS, Agashe GS, Sawamura S et al. Glucocorticoid inhibition of neuropathic hyperalgesia and spinal fos expression. Anesth Analg 2001; 92: 476-482.